StoneX Group Inc.

SNEX

Held by 1 specialist biotech fund

Share on X

Fund Holdings

Driehaus Capital

AI Signal

AI analyst context — unlock full analysis

Catalysts

No catalysts tracked.

Position Details

Driehaus CapitalNEWFeb 17, 2026

Shares: 483,833Value: $46.0M

**Signal Note: Driehaus Initiates $46M Position in StoneX Group** This move is notable as a growth-focused manager backs a financial services/commodities trading platform rather than a direct biotech play, suggesting conviction in StoneX's fintech infrastructure positioning or potential M&A appeal. The $46M position size is material for Driehaus but represents a sector rotation away from drug-development bets, warranting clarification on whether this reflects portfolio rebalancing or a specific catalyst in financial services/blockchain adoption.

More SNEX Analysis

Insider buy/sell details with names, titles, and amounts
AI-generated context for every signal

Start 7-Day Free Trial — $29/mo

Insider Signals

No insider signals tracked.

Also Held by These Funds

PTN1 fund WLDN1 fund LASR1 fund ONTO1 fund VALE1 fund TNDM1 fund TKO1 fund TNL1 fund

Research Links

Yahoo Finance →SEC EDGAR →ClinicalTrials.gov →

Track specialist biotech funds, insider signals, and AI analysis

Start 7-Day Free Trial

Or get the free weekly brief: